| Analysis | Metabolite Name | Measured Value | Units | Diagnosis | Dysplasia |
|---|---|---|---|---|---|
| 6530 Q-TOF/C18 NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | 28372 | Peak area | IPMN | LGD |
| 6530 Q-TOF/C18 NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | 30287 | Peak area | MCN | LGD |
| 6530 Q-TOF/C18 NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | 47637 | Peak area | IPMN | LGD |
| 6530 Q-TOF/C18 NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | 83257 | Peak area | SCA | N/A |
| 6530 Q-TOF/C18 NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | 96458 | Peak area | IPMN | LGD |
| 6530 Q-TOF/C18 NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | 312354 | Peak area | MCN | LGD |
| 6530 Q-TOF/C18 NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | 414440 | Peak area | MCN | LGD |
| 6530 Q-TOF/C18 NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | 1006497 | Peak area | IPMN | LGD |
| 6530 Q-TOF/C18 NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | 1614121 | Peak area | SCA | N/A |
| 6530 Q-TOF/C18 NEGATIVE ION MODE | 5-OXOPROLINE (M-H)- | 2299135 | Peak area | SCA | N/A |
| 6530 Q-TOF/C18 POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 271716 | Peak area | SCA | N/A |
| 6530 Q-TOF/C18 POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 272788 | Peak area | IPMN | LGD |
| 6530 Q-TOF/C18 POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 323994 | Peak area | MCN | LGD |
| 6530 Q-TOF/C18 POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 371289 | Peak area | MCN | LGD |
| 6530 Q-TOF/C18 POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 892741 | Peak area | IPMN | LGD |
| 6530 Q-TOF/C18 POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 1417260 | Peak area | SCA | N/A |
| 6530 Q-TOF/C18 POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | 1684444 | Peak area | SCA | N/A |
| 6530 Q-TOF/C18 POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | Peak area | IPMN | LGD | |
| 6530 Q-TOF/C18 POSITIVE ION MODE | 5-OXOPROLINE (M+H)+ | Peak area | MCN | LGD | |
| 6530 Q-TOF/C18 POSITIVE ION MODE | 5-OXOPROLINE (M+Na)+ | 20778 | Peak area | SCA | N/A |
| 6530 Q-TOF/C18 POSITIVE ION MODE | 5-OXOPROLINE (M+Na)+ | 22845 | Peak area | SCA | N/A |
| 6530 Q-TOF/C18 POSITIVE ION MODE | 5-OXOPROLINE (M+Na)+ | 26064 | Peak area | SCA | N/A |
| 6530 Q-TOF/C18 POSITIVE ION MODE | 5-OXOPROLINE (M+Na)+ | 26369 | Peak area | IPMN | LGD |
| 6530 Q-TOF/C18 POSITIVE ION MODE | 5-OXOPROLINE (M+Na)+ | 28433 | Peak area | IPMN | LGD |
| 6530 Q-TOF/C18 POSITIVE ION MODE | 5-OXOPROLINE (M+Na)+ | 28557 | Peak area | MCN | LGD |
| 6530 Q-TOF/C18 POSITIVE ION MODE | 5-OXOPROLINE (M+Na)+ | 28742 | Peak area | MCN | LGD |
| 6530 Q-TOF/C18 POSITIVE ION MODE | 5-OXOPROLINE (M+Na)+ | 31941 | Peak area | IPMN | LGD |
| 6530 Q-TOF/C18 POSITIVE ION MODE | 5-OXOPROLINE (M+Na)+ | 36554 | Peak area | IPMN | LGD |
| 6530 Q-TOF/C18 POSITIVE ION MODE | 5-OXOPROLINE (M+Na)+ | 37343 | Peak area | MCN | LGD |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|